Centessa Pharmaceuticals (CNTA) FY Conference Transcript

Centessa Pharmaceuticals (CNTA) FY Conference June 10, 2025 09:20 AM ET Speaker0 Good morning, everyone. Thanks so much for joining us. I'm Andrea Newkirk, one of the biotech analysts at Goldman Sachs, and I'm really pleased to be joined by Saurabh Saha, CEO of Sentessa. Thanks so much for joining us. Speaker1 Thank you, Andrea. Great to be here. Speaker0 Maybe we can start at a high level. Over the last year, you've transitioned fully or almost fully to an orexin focused company. Maybe talk us through your ...